S. Peter Goedegebuure

CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models

Yu Zhu, Brett L. Knolhoff, Melissa A. Meyer et al. · Cancer Research · 2014 · 1.3K citations · Full text

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Timothy M. Nywening, Andrea Wang‐Gillam, Dominic E. Sanford et al. · The Lancet Oncology · 2016 · 746 citations · Full text

Pancreatic Cancer, Tumour-associated Macrophages, Medicine +8

Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis

Dominic E. Sanford, Brian A. Belt, Roheena Z. Panni et al. · Clinical Cancer Research · 2013 · 597 citations · Full text

Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids

Venktesh S. Shirure, Ye Bi, Matthew B. Curtis et al. · Lab on a Chip · 2018 · 278 citations · Full text

Engineering, Biological Microenvironments, Organ-on-a-chip +22

Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer

Roheena Z. Panni, Dominic E. Sanford, Brian A. Belt et al. · Cancer Immunology Immunotherapy · 2014 · 216 citations · Full text